Stock Ratings / Industrials / MLAB / dividends

EOSE (28) ENVX (31) KRNT (50) GHM (52) ⌘ Pro Terminal →

Mesa Laboratories Inc. (MLAB) Dividend Safety Gauge & 10-Year DRIP Compounder

$133.03 +1.30% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $133.09

Mesa Laboratories Inc. (MLAB) carries a Roarable Rating of D+ (Sell) with 55/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record: Scores of 55/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.5% avg 90D alpha vs SPY) →

ROARABLE D+ • SELL / AVOID Cap $744.4M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $133.08 (+0.04%)🧬 Cannibal Buyback (-0.96% YoY Shares)⚙️ Cash Engine: 10/20 (D) • 15.9% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 55/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.5% avg 90D alpha vs SPY • 51.4% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERSELL / AVOID • D+

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D · Rk C

Each axis scored 0–20

12M PRICE TARGET CONE-1.4% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for MLAB)Realized 20D OHLCV Swing Band: ±8.1%

Deterministic 5-Pillar Attribution (55/100 Composite)

🔍 WHY MLAB SCORES 55/100 (D+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+14/20 pts (25% of score)

Altman Z-Score 2.07 (WATCH ZONE (1.8–3.0)) • Piotroski F-Score 7/9

▲ #2 Bullish Driver: Macro Regime Fit+12/20 pts (22% of score)

FRED Regime × Technicals: 85% of 52W Range • RSI-14 at 49 (NEUTRAL RANGE)

▼ #1 Drag / Risk Factor: Whale & Options Positioning8/20 pts (-12 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-12 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade D$127.51-3.9% Next Q

Q2 (-2Q)

Grade C-$122.48+5% Next Q

Q3 (-1Q)

Grade C-$128.66+3.4% Next Q

Current

Grade D+$133.03-0.5% Hist 90D α

Trajectory: D (47) → D+ (55)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the MLAB Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 55/100 (D+) score, MLAB faces multiple-compression risk if 110.9x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Priced at 111x earnings—high expectations leave less room for a lukewarm quarter.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-0.96% YoY Shares) — any gross margin slip below 61.0% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($128.52) or 200D SMA ($104.18) invalidates the momentum regime and cuts Target Base ($131.23) toward Bear Floor ($102.36).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $MLAB• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “MLAB Beats Next Quarter EPS Consensus (Dec 29, 2026) & Holds Above 200D SMA”

YES 55%NO 45%Trade / Inspect Odds →

CASH DIVIDEND + BUYBACK YIELD

2.27% Total Yield

0.47% Cash ($0.63/yr) + 1.8% Buybacks

PAYOUT SAFETY SPEEDOMETER

88/100 • FORTRESS PAYOUT

FREE CASH FLOW PAYOUT RATIO

14% of FCF

8 consecutive years of payout growth

INTERACTIVE DRIP & SHAREHOLDER-YIELD COMPOUNDER (5.8% EST. ANNUAL)

$10,000 Compounded Over 10 Years → $17,573

Est. Year-10 Shareholder Yield: $399/yr

Starting Investment: $10,000

Compounding Horizon: 10 Years

$10.6K

Yr 1

$11.2K

Yr 2

$11.8K

Yr 3

$12.5K

Yr 4

$13.3K

Yr 5

$14.0K

Yr 6

$14.8K

Yr 7

$15.7K

Yr 8

$16.6K

Yr 9

$17.6K

Yr 10

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring MLAB)

✓Walkthrough of MLAB's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

MLAB // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +33.03%▲ ASCENDING CHANNEL

2026-10-30O $132.4H $133.0L $127.1C $133.0VOL 73.2K

RES: $154.4SUP: $105.9SMA50: $128.5SMA200: $104.2

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

MLAB Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 MLAB Butterfly Map → + Track MLAB →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

48.0%/yr Implied 5Y Growth

vs. +3.4% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on MLAB today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for MLAB. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for MLAB today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (MLAB)

Industrials Rank #243 of 485 ⚔️ EOSE vs MLAB Full Matrix →

1. Head-to-Head Industrials Peer Comparison (MLAB vs. EOSE, ENVX, KRNT, GHM)

Industry: Industrial Machinery/Components (208 Tracked Issuers)

Across 485 tracked Industrials securities in the Roarable RQD universe, Mesa Laboratories Inc. (MLAB) ranks #243 by composite RQD confidence (55/100, grade D+) and #273 by equity capitalization ($744.4M). Within this direct 5-issuer industry benchmark cohort, GHM leads on earnings valuation at 67.3x trailing P/E, while GHM leads on capital efficiency and profitability with 10.9% ROIC and 23.5% gross margin. MLAB currently leads its immediate peer cohort in composite quantitative strength at 55/100 (D+).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
MLAB ACTIVE Mesa Laboratories Inc.	D+	55/100	110.9x	63.5%	9.3%	+1.30%	$744.4M	Benchmark Subject
EOSE Eos Energy Enterprises Inc. (Class A)	E	28/100	—	-30.0%	-35.0%	+1.54%	$721.1M	/eose-vs-mlab →
ENVX Enovix Corporation	E	31/100	—	19.2%	-20.5%	-0.28%	$770.3M	/envx-vs-mlab →
KRNT Kornit Digital Ltd.	D	50/100	—	44.3%	-4.0%	+0.11%	$780.7M	/krnt-vs-mlab →
GHM Graham Corporation	D+	52/100	67.3x	23.5%	10.9%	+0.75%	$841.4M	/ghm-vs-mlab →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2026-03-31 • CIK 0000724004

In its most recent audited fiscal period (FY2025, filed 2026-03-31), Mesa Laboratories Inc. (MLAB) reported GAAP revenue of $249.1M (+3.4% vs. FY2024 revenue of $241.0M , and +15.2% cumulative change since FY2023) , GAAP net income of $6.7M, operating cash flow of $42.8M, and free cash flow of $39.6M (-7.0% YoY). On the balance sheet, MLAB closed FY2025 with $434.8M in total assets against $0 in total debt (Altman Z-Score: 2.07, Piotroski F-Score: 7/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2026-03-31	$249.1M	$6.7M	$42.8M	$39.6M	$434.8M	—
FY2024 (FY)	2025-03-31	$241.0M	-$2.0M	$46.8M	$42.6M	$433.3M	—
FY2023 (FY)	2024-03-31	$216.2M	-$254.2M	$44.1M	$44.1M	—	—

3. MLAB Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is MLAB stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Mesa Laboratories Inc. (NASDAQ: MLAB) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 55/100 at a spot price of $133.03 (+1.30% 1D, market cap $744.4M). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 8/20, Executive Insider Alignment 14/20, FRED Macro Regime Fit 12/20, and SEC Balance-Sheet Forensics 11/20. Across 485 tracked Industrials issuers, MLAB ranks #243 in composite RQD confidence.

How does MLAB compare to EOSE and ENVX in the Industrials sector?

Within the Industrials sector (Industrial Machinery/Components), MLAB carries a Roarable D+ (55/100 RQD), trailing P/E of 110.9x, gross margin of 63.5%, and ROIC of 9.3%. By comparison, EOSE (Eos Energy Enterprises Inc. (Class A)) holds a E grade (28/100 RQD, P/E N/A, ROIC -35.0%, cap $721.1M) and ENVX (Enovix Corporation) posts a E grade (31/100 RQD, P/E N/A, ROIC -20.5%, cap $770.3M). Among the 5-stock peer group, GHM leads on earnings multiple (67.3x) while GHM leads on capital efficiency (10.9% ROIC).

What are the biggest fundamental strengths and SEC risk factors for MLAB?

Per MLAB's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-03-31, CIK 0000724004), Mesa Laboratories Inc. generated $249.1M in revenue (+3.4% YoY), $6.7M in net income, and $39.6M in free cash flow against $434.8M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Industrials with deep daily trading liquidity.. Primary risk factors monitored: Priced at 111x earnings—high expectations leave less room for a lukewarm quarter.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is MLAB trading relative to its 50-day, 200-day, and 52-week technical levels?

MLAB last traded at $133.03 (+1.30% on volume of 60,937 shares), positioning the stock +3.51% above its 50-day simple moving average ($128.52) and +27.69% above its 200-day simple moving average ($104.18). Across its 52-week range of $69.51 to $144.35, MLAB sits at the 84.9% percentile with a 14-day RSI of 49.0 (NEUTRAL RANGE) and an implied next-earnings move of ±8.1% ($122.25 to $143.81).

MLAB Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Does MLAB pay a dividend and is it safe?

Mesa Laboratories Inc. (MLAB) offers a 0.47% cash dividend yield ($0.63 annualized) and 2.27% total shareholder yield including buybacks. Roarable rates its payout coverage as FORTRESS PAYOUT.

Direct Sub-Reports: MLAB RQD Cockpit MLAB 12M Forecast MLAB Earnings & Move MLAB Dividends & DRIP MLAB Insiders & 13F MLAB Whale Options MLAB Profit Sankey MLAB News & Why